文献速递妇科

妇科恶性肿瘤与盆底功能障碍同期手术后的不良事件

Adverse Events After Concurrent Procedures for Gynecologic Malignancies and Pelvic Floor Disorders.
PubMed 文献 · Obstet Gynecol · 2018-01-01

基于美国外科医师学会国家质量改进项目数据库,纳入2013至2016年间因妇科癌症接受手术的患者,其中589例(2.3%)同期行盆底重建。经倾向评分匹配后比较488例联合手术与976例单纯肿瘤手术,联合手术组输血更常见(7.2% vs 3.6%,OR 1.7,95% CI 1.1-2.8),任何术后不良事件发生率差异未达统计学显著(8.2% vs 5.5%,OR 1.5,95% CI 0.99-2.3)。

要点

  • 匹配后联合手术组输血率7.2%,单纯肿瘤手术组3.6%(OR 1.7,95% CI 1.1-2.8)。
  • 任何术后不良事件联合组8.2% vs 对照组5.5%,OR 1.5(95% CI 0.99-2.3),未达统计学显著。

核心结论

  • 联合重建与肿瘤手术与任何术后不良事件风险及输血风险的低度但统计学显著的增加相关。

研究设计与样本

  • 基于美国外科医师学会国家质量改进项目数据库,识别2013至2016年间因妇科癌症接受手术并伴或不伴盆底重建的患者。
  • 采用倾向评分匹配以改善选择偏倚,匹配后联合手术组488例,单纯肿瘤手术对照组976例。

主要发现

  • 匹配后任何术后不良事件发生率联合组8.2% vs 对照组5.5%,OR 1.5(95% CI 0.99-2.3),未达统计学显著。
  • 术后输血联合组7.2% vs 对照组3.6%,OR 1.7(95% CI 1.1-2.8)。
  • 逻辑回归显示卵巢癌(调整OR 7.9,95% CI 4.9-12.7)和脱垂手术(调整OR 1.7,95% CI 1.0-2.7)仍与任何术后不良事件显著相关。
  • 卵巢癌(调整OR 10.0,95% CI 5.9-17.3)和脱垂手术(调整OR 2.1,95% CI 1.2-3.6)仍与术后输血发生率升高显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the incidence and trends of 30-day outcomes after concurrent surgeries for gynecologic cancer and pelvic floor disorders. METHODS: Using the American College of Surgeons National Quality Improvement Program database, patients who underwent surgery for gynecologic cancer with and without pelvic floor reconstruction were identified between the years 2013 and 2016. Propensity score matching was performed to ameliorate selection. Student t test and Mann-Whitney tests were used to compare continuous variables between two groups where appropriate. The χ and Fisher exact tests were used where appropriate to compare categorical variables across groups. Logistic regression models were used to evaluate factors associated with any adverse event and with postoperative transfusion specifically. RESULTS: Twenty-five thousand one hundred thirty-eight patients underwent oncologic surgery and 589 (2.3%) of these had concurrent pelvic reconstruction during the study period. After propensity matching, there were 488 combined cases; 976 oncologic-only cases were selected as controls. There were no statistically significant differences across any of the baseline characteristics between groups. Although more common in the combined than in the control cohort, the incidence of any postoperative adverse event (8.2% vs 5.5%, odds ratio [OR] 1.5, 95% CI 0.99-2.3) was not statistically significant between groups. Postoperative blood transfusions, however, were more common in the combined cohort than in the control cohort (7.2% vs 3.6%, OR 1.7, 95% CI 1.1-2.8). After logistic regression, ovarian cancer (adjusted OR 7.9, 95% CI 4.9-12.7) and prolapse surgery (adjusted OR 1.7, 95% CI 1.0-2.7) remained significantly associated with any postoperative adverse events. Similarly, ovarian cancer (adjusted OR 10.0, 95% CI 5.9-17.3) and prolapse surgery (adjusted OR 2.1, 95% CI 1.2-3.6) remained significantly associated with a higher incidence of postoperative blood transfusions. CONCLUSION: Combined reconstructive and oncologic surgery is associated with a low but statistically significant increase in the risk of any postoperative adverse event and specifically blood transfusions.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bretschneider CE, Sheyn D, Mahajan ST, et al. Adverse Events After Concurrent Procedures for Gynecologic Malignancies and Pelvic Floor Disorders. Obstet Gynecol. 2018. PMID: 29995734. doi:10.1097/AOG.0000000000002731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。